Literature DB >> 15490090

[Organ transplantation in endocrinology. Islet cells and pancreas].

E Jaeckel1, T Becker, M P Manns.   

Abstract

Pancreas transplantation is a successful and effective procedure resulting in tight glucose control. Due to the postoperative morbidity and the need for immunosuppression pancreas transplantation should be considered at the time of kidney transplantation. Besides this, pancreas transplantation alone should be considered for patients with unacceptably poor metabolic control and quality of life despite optimal medical treatment. Recently, islet transplantation became a less invasive alternative to pancreas transplantation. Due to the lack of long-term follow-up and due to the need of multiple donor grafts for one recipient, islet transplantation should be performed under experimental settings in experienced centers. New developments in protecting transplanted islets and in the induction of donor-specific tolerance could increase the indication to perform the procedure. Therefore alternative sources of beta-cells have to be identified.

Entities:  

Mesh:

Year:  2004        PMID: 15490090     DOI: 10.1007/s00108-004-1303-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  36 in total

1.  Adverse events and their association with treatment regimens in the diabetes control and complications trial.

Authors: 
Journal:  Diabetes Care       Date:  1995-11       Impact factor: 19.112

2.  Variables in organ donors that affect the recovery of human islets of Langerhans.

Authors:  J R Lakey; G L Warnock; R V Rajotte; M E Suarez-Alamazor; Z Ao; A M Shapiro; N M Kneteman
Journal:  Transplantation       Date:  1996-04-15       Impact factor: 4.939

Review 3.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

4.  Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy.

Authors:  G Tydén; J Tollemar; J Bolinder
Journal:  Clin Transplant       Date:  2000-10       Impact factor: 2.863

5.  Glucose-dependent insulin release from genetically engineered K cells.

Authors:  A T Cheung; B Dayanandan; J T Lewis; G S Korbutt; R V Rajotte; M Bryer-Ash; M O Boylan; M M Wolfe; T J Kieffer
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

6.  Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients.

Authors:  Paolo Fiorina; Franco Folli; Federico Bertuzzi; Paola Maffi; Giovanna Finzi; Massimo Venturini; Carlo Socci; Alberto Davalli; Elena Orsenigo; Lucilla Monti; Luca Falqui; Silvia Uccella; Stefano La Rosa; Luciana Usellini; Giuliana Properzi; Valerio Di Carlo; Alessandro Del Maschio; Carlo Capella; Antonio Secchi
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

7.  [Successful allotransplantation of an island of Langerhans].

Authors:  F Largiadèr; E Kolb; U Binswanger; R Illig
Journal:  Schweiz Med Wochenschr       Date:  1979-11-24

8.  Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure.

Authors:  Y F Smets; R G Westendorp; J W van der Pijl; F T de Charro; J Ringers; J W de Fijter; H H Lemkes
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

9.  Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients.

Authors:  V Douzdjian; J C Rice; K K Gugliuzza; J C Fish; R W Carson
Journal:  Am J Kidney Dis       Date:  1996-01       Impact factor: 8.860

Review 10.  Clinical trials of transplant tolerance: slow but steady progress.

Authors:  Jeffrey B Matthews; Eleanor Ramos; Jeffrey A Bluestone
Journal:  Am J Transplant       Date:  2003-07       Impact factor: 8.086

View more
  1 in total

1.  The rational design of beta cell cytoprotective gene transfer strategies: targeting deleterious iNOS expression.

Authors:  Cillian McCabe; Timothy O'Brien
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.